Central Research Associates - Flourish - PPDS

Clinical research site in Birmingham, Alabama · Flourish Research - Birmingham, 2660 10th Ave S Suite 735, Building 1, Birmingham, AL 35205 · (205) 208-9244 · Website

As of July 2026, 14 paid clinical trials are recruiting at Central Research Associates - Flourish - PPDS in Birmingham, Alabama. Active studies at this site cover conditions such as Acute Hepatic Porphyria, Generalized Myasthenia Gravis and High Cardiovascular Risk. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Central Research Associates - Flourish - PPDS (14)

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

for Diabetes Mellitus, Type 2

25 locations incl. Birmingham

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18 - 75

Code: NCT07668388·Phase 2·Recruiting·Listed Jun 25, 2026

Apply to this trial

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

for Lichen Planopilaris

47 locations incl. Birmingham

Sponsor: Priovant Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07532603·Phase 2, Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

for Overweight

59 locations incl. Birmingham

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07392190·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

for Type II Diabetes Mellitus

31 locations incl. Birmingham

Sponsor: Corxel Pharmaceuticals

Sex: All·Age: 18 - 75

Code: NCT07340320·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

for Overweight

60 locations incl. Birmingham

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07282600·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

for Cardiovascular Disease

201 locations incl. Alexander City

Sponsor: Amgen

Sex: All·Age: 50 - 105

Code: NCT07136012·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

for High Risk Cardiovascular Disease

261 locations incl. Birmingham

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07181109·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

for Chronic Inflammatory Demyelinating Polyneuropathy

32 locations incl. Birmingham

Sponsor: Dianthus Therapeutics

Sex: All·Age: 18 - 75

Code: NCT06858579·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

for Generalized Myasthenia Gravis

32 locations incl. Birmingham

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT04202341·Recruiting·Listed Dec 2019

Apply to this trial

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

for Knee Cartilage Defects

20 locations incl. Birmingham

Sponsor: Medipost, Inc.

Sex: All·Age: 18 - 75

Code: NCT07339111·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

for Locally Advanced / Metastatic Solid Tumors

14 locations incl. Birmingham

Sponsor: Crescent Biopharma, Inc.

Sex: All·Age: 18+

Code: NCT07335497·Phase 1, Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

for Acute Hepatic Porphyria

11 locations incl. Birmingham

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: 12+

Code: NCT04883905·Recruiting·Listed May 2021

Apply to this trial

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

for Hepatocellular Carcinoma (HCC)

13 locations incl. Birmingham

Sponsor: RayzeBio, Inc.

Sex: All·Age: 18+

Code: NCT06726161·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

for Alpha 1-Antitrypsin Deficiency

3 locations incl. Birmingham

Sponsor: Beam Therapeutics Inc.

Sex: All·Age: 18 - 70

Code: NCT06389877·Phase 1, Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

More research sites in Birmingham

University of Alabama at Birmingham (331 trials)
Children's Hospital of Alabama (39 trials)
University of Alabama (33 trials)
University of Alabama at Birmingham Cancer Center (30 trials)
The University of Alabama at Birmingham (27 trials)
University of Alabama Birmingham (27 trials)
UAB (15 trials)
Children's of Alabama (15 trials)
University of Alabama Hospital (13 trials)
Birmingham VA Medical Center, Birmingham, AL (10 trials)

Explore more

Paid clinical trials in Birmingham, AL · Alabama clinical trials